- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 9/12 - Antihypertensives
Patent holdings for IPC class A61P 9/12
Total number of patents in this class: 3984
10-year publication summary
154
|
162
|
134
|
193
|
276
|
257
|
258
|
291
|
268
|
70
|
2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Daiichi Sankyo Company, Limited | 1829 |
77 |
Novartis AG | 11238 |
76 |
Takeda Pharmaceutical Company Limited | 2961 |
68 |
Actelion Pharmaceuticals Ltd | 576 |
43 |
Sunshine Lake Pharma Co., Ltd. | 542 |
35 |
Taisho Pharmaceutical Co., Ltd. | 844 |
34 |
Mitsubishi Tanabe Pharma Corporation | 579 |
32 |
F. Hoffmann-La Roche AG | 7958 |
26 |
United Therapeutics Corporation | 291 |
26 |
Shionogi & Co., Ltd. | 914 |
25 |
Dainippon Sumitomo Pharma Co., Ltd. | 234 |
23 |
Acceleron Pharma Inc. | 365 |
21 |
Banyu Pharmaceutical Co., Ltd. | 107 |
21 |
Nippon Shinyaku Co., Ltd. | 297 |
21 |
Japan Tobacco Inc. | 3225 |
20 |
Janssen Pharmaceutica N.V. | 3839 |
19 |
Boehringer Ingelheim Vetmedica GmbH | 1290 |
18 |
Bayer Pharma AG | 1096 |
18 |
ASKA Pharmaceutical Co., Ltd. | 104 |
18 |
Kowa Company, Ltd. | 1172 |
18 |
Other owners | 3345 |